Literature DB >> 1395104

Endothelial cell damage in primary biliary cirrhosis: influence of cholestasis and immunological mechanisms.

A D Blann1, C Babbs, J M Neuberger.   

Abstract

In a study looking for evidence of endothelial cell damage in primary biliary cirrhosis, serum from patients was found to be significantly more cytotoxic to cultured endothelial cells in vitro than normal control serum (P less than 0.001). Serum also contained higher levels of von Willebrand factor antigen (vWFAg, a specific product of the endothelium) than control serum (P less than 0.001). Cytotoxicity correlated with serum levels of vWFAg (P less than 0.05) and with serum bilirubin (P less than 0.05). No correlations were found between cytotoxicity and circulating immune complexes, C-reactive protein or CH50. The study was controlled by serum from patients with other liver diseases. In these samples vWFAg (P less than 0.003), and bilirubin levels (P less than 0.001) were also raised relative to normal controls. vWFAg levels again correlated with levels of bilirubin (P less than 0.05). Tissue culture experiments showed that purified bilirubin was cytotoxic to human umbilical vein endothelial cells and induced the release of vWFAg. The case report of a patient with obstructive jaundice again indicated that levels of bilirubin and vWFAg were related. These results suggest that endothelial cell damage occurs in both primary biliary cirrhosis and to a lesser extent in other liver diseases, and may be mediated by cholestasis, not by humoral immunological mechanisms.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1395104      PMCID: PMC1554559          DOI: 10.1111/j.1365-2249.1992.tb05837.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction.

Authors:  A J Wakefield; A M Sawyerr; A P Dhillon; R M Pittilo; P M Rowles; A A Lewis; R E Pounder
Journal:  Lancet       Date:  1989-11-04       Impact factor: 79.321

Review 2.  The role of complement and its receptor in the elimination of immune complexes.

Authors:  J A Schifferli; Y C Ng; D K Peters
Journal:  N Engl J Med       Date:  1986-08-21       Impact factor: 91.245

3.  The presentation and diagnosis of 100 patients with primary biliary cirrhosis.

Authors:  S Sherlock; P J Scheuer
Journal:  N Engl J Med       Date:  1973-09-27       Impact factor: 91.245

4.  Complement activation in primary biliary cirrhosis: an in vitro model.

Authors:  S Lindgren; U Johnson
Journal:  J Lab Clin Med       Date:  1985-04

5.  Indium 111 (111In) as a label for endothelial cells and fibroblasts used as target cells in cytotoxicity tests.

Authors:  A D Blann; C M Garner
Journal:  Med Lab Sci       Date:  1985-01

6.  Circulating immune complexes and the pathogenesis of primary biliary cirrhosis.

Authors:  E A Jones; S P James
Journal:  Gastroenterology       Date:  1982-09       Impact factor: 22.682

7.  Differential expression of MHC class II subregion products on bile duct epithelial cells and hepatocytes in patients with primary biliary cirrhosis.

Authors:  U Spengler; G R Pape; R M Hoffmann; J P Johnson; J Eisenburg; G Paumgartner; G Riethmüller
Journal:  Hepatology       Date:  1988 May-Jun       Impact factor: 17.425

8.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

9.  Complement-activating rheumatoid-factor-containing complexes in patients with rheumatoid vasculitis.

Authors:  C J Elson; D G Scott; D R Blake; P A Bacon; P D Holt
Journal:  Ann Rheum Dis       Date:  1983-04       Impact factor: 19.103

10.  Acute hepatitis B associated with gynaecological surgery.

Authors: 
Journal:  Lancet       Date:  1980-01-05       Impact factor: 79.321

View more
  2 in total

1.  Capillarization of hepatic sinusoid by liver endothelial cell-reactive autoantibodies in patients with cirrhosis and chronic hepatitis.

Authors:  Bo Xu; Ulrika Broome; Mehmet Uzunel; Silvia Nava; Xupeng Ge; Makiko Kumagai-Braesch; Kjell Hultenby; Birger Christensson; Bo-Göran Ericzon; Jan Holgersson; Suchitra Sumitran-Holgersson
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

Review 2.  Bench-to-bedside review: endothelial cell dysfunction in severe sepsis: a role in organ dysfunction?

Authors:  Benoît Vallet
Journal:  Crit Care       Date:  2003-01-06       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.